Clinical Trials Sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Total 249 results

Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project (Eternity)

Cervical Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC) (ProphyPIPAC)

Peritoneal Metastases From Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

A Retrospective Study on Multiple Classifier Endometrial Cancer

Uterine Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

The ImmunoXXL Study (ImmunoXXL)

Hepatocellular Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

Metastatic Clear Cell Renal Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients (Agility)

Melanoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer (CATARTIC)

Rectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Palliative Care Referral System (PCRS) for Cancer Patients With Advanced Disease (PCRSS)

Advanced Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

Metastatic Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET (LOLA)

Neuroendocrine Tumors | Metastatic Well Differentiated Neuroendocrine Neoplasm

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

PATIENT VOICES Integration of Systematic Assessment of Patient Reported Outcomes Within Clinical Oncology Practice

Neoplasms | Quality of Life | Psychological Distress | Symptoms and Signs | Satisfaction, Consumer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study" (ARCADIA)

Bladder Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Radiomics and Machine Learning in the Diagnosis of Ovarian Masses (Multi-AROMA)

Ovarian Cysts | Ovarian Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma

Metastatic Urothelial Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Molecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With Vandetanib

Metastatic Sporadic Medullary Thyroid Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients (CAPTEM)

Metastatic Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Terminated

A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic Anesthesia (DATA)

Neuromuscular Blockade

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

caBozantinib in cOllectiNg ductS Renal Cell cArcInoma (BONSAI)

Collecting Duct Carcinoma (Kidney)

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Withdrawn

Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study (PECULIAR)

Muscle-invasive Bladder Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen) (CaboPen)

Penile Squamous Cell Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial. (TOCANNATO)

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIb (PIPELINE)

Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14 (ACC-LEN14)

Adenoid Cystic Carcinomas of the Salivary Glands

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Alisertib in Chemotherapy-pretreated Urothelial Cancer

Transitional Cell Carcinoma | Bladder Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Nutritional Status in Retroperitoneal Sarcoma. (NOVA)

Malnutrition | Retroperitoneal Sarcoma
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Cancer Anesthesia and Frailty

Cancer | Anesthesia | Fragility

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Terminated

Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study) (TOKIO)

Renal Cancer Cell

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)

Multiple Myeloma
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Skin Squamous Cell Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

TARC After alloSCT in Hodgkin's Lymphoma (TARC)

Hodgkin's Lymphoma Patients Who Underwent an Allogeneic Stem Cell Transplantation

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Prospective Observational Study on Plerixafor After Chemotherapy

Lymphoma | Myeloma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

A Questionnaire to Assess the Quality of Life of Rectal Cancer Patients With or Without Stoma

Rectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC) (PANDORA)

Merkel Cell Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC) (OrganoHIPEC)

Peritoneal Metastases From Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Treatments of HPV-related Lesions

Cervical Cancer | HPV | Cervix Lesion | Vagina Disease
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Indocyanine Green-guided Lymphadenectomy in Laparoscopic Total Mesorectal Excision for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy ((GreenEye-CRC))

Rectal Cancer | Lymph Node Cancer Metastatic

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy (Serpentine)

Melanoma | Renal Cell Carcinoma | Breast Cancer | NSCLC | Urinary Bladder Cancer | Squamous Cell Carcinoma of Head and Neck | Small Cell Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients (ACAPP)

Pseudomyxoma Peritonei

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients (WIN-HYPO2021)

Hypothyroidism; Irradiation

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer (LIQUID)

Gastric Cancer | Gastric Adenocarcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) (Style)

Thymic Carcinoma | Type B3 Thymoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers (ARMANI)

Stomach Neoplasms

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Activity of Sorafenib in Salivary Gland Cancer

Salivary Gland Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone

Post Operative Pain | Hyperalgesia

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Enrolling by invitation

Gene Expression Profile of Resected Pancreatic and Ampullary Adenocarcinoma at Favorable Prognosis

Resectable Pancreatic Adenocarcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention (DietINT)

Cancer of Head and Neck

Austria, Slovenia, Germany, Italy, Poland, Portugal
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer (MAYA)

Metastatic Colorectal Cancer

Italy

Clinical Trials Sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations